Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers.
about
Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detectionSerum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various gradesCirculating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer.Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer.MGMT promoter methylation in serum and cerebrospinal fluid as a tumor-specific biomarker of gliomaDetection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma.Discrimination of gastric cancer from normal by serum RNA based on surface-enhanced Raman spectroscopy (SERS) and multivariate analysisIncreased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese womenEpigenetic resensitization to platinum in ovarian cancerCirculating nucleic acids in plasma and serum (CNAPS): applications in oncology.Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the diseaseA serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls.Circulating miRNA and cancer diagnosis.Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma.Biomedical optical spectroscopy for the early diagnosis of gastrointestinal neoplasms.Circulating microRNAs in plasma of patients with gastric cancers.Potential Diagnostic and Prognostic Value of Lymphocytic Mitochondrial DNA Deletion in Relation to Folic Acid Status in HCV-Related Hepatocellular CarcinomaIncidence and prognostic value of multiple gene promoter methylations in gliomas.Circulating tumour-derived DNA in metastatic soft tissue sarcoma.
P2860
Q24646396-0AD5D2F1-4791-47BF-AF8E-90566D6A4DADQ34132740-D5CA1B3C-A4CF-480A-AFFD-46314120E9E3Q35108381-1A1198EA-968F-430C-B303-E41C10626075Q35623347-E659D241-706C-48C4-BD35-921D0791BF81Q35740045-6C9AA00B-CAAE-49EE-9754-2D473FA78883Q35803479-96CD894F-364A-443D-BDCB-E6EDBE7A7939Q35879824-FCBB8238-D6F9-4421-85AB-7DB3C12348CAQ36236405-9348AE15-8190-4549-A6DA-374AD0407453Q36354286-B469B2A5-8D17-40BB-9256-277F727E6B49Q36979382-C578809E-0EDD-4AD1-9B35-27FC9624DEEEQ37014663-482A8029-5EFF-43CE-B0AE-D42875196E56Q37295740-5629D17C-B878-47A3-841E-0E9C7F119B17Q37499241-0837240F-6E89-4483-937C-F234F0C19895Q37657193-8D8C0D59-D5EB-47D5-B765-7E38213FEEB7Q37822465-4143272C-14CA-4147-B098-55D305E97568Q38270678-90D8B083-AA0E-4B9D-A03F-49ED3611F1B4Q39410778-335930FE-C07F-4284-B7D4-1F9B245D315FQ39986294-D99DFE30-9D28-4282-82F8-5FB1255AF643Q41929602-2B8382FF-C1CD-4477-8EAD-453504CCE6DDQ44664373-E5EBD38F-3099-4548-A281-CC945A231A2DQ52356767-91AC806D-E805-4411-A0AF-559AB395956A
P2860
Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Circulating tumour-derived nuc ...... pplications as tumour markers.
@ast
Circulating tumour-derived nuc ...... pplications as tumour markers.
@en
type
label
Circulating tumour-derived nuc ...... pplications as tumour markers.
@ast
Circulating tumour-derived nuc ...... pplications as tumour markers.
@en
prefLabel
Circulating tumour-derived nuc ...... pplications as tumour markers.
@ast
Circulating tumour-derived nuc ...... pplications as tumour markers.
@en
P2860
P921
P356
P1476
Circulating tumour-derived nuc ...... pplications as tumour markers.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603625
P407
P577
2007-02-20T00:00:00Z
2007-03-12T00:00:00Z